Tenor Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Tenor Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125,000	Closed	-$7K	–	401
2023 Q3	$7K	Hold	125,000	–	–	﹤0.01%	281
2023 Q2	$18.4K	Hold	125,000	–	–	﹤0.01%	240
2023 Q1	$11.9K	Hold	125,000	–	–	﹤0.01%	334
2022 Q4	$12.5K	Hold	125,000	–	–	﹤0.01%	409
2022 Q3	$10K	Hold	125,000	–	–	﹤0.01%	589
2022 Q2	$17K	Hold	125,000	–	–	﹤0.01%	613
2022 Q1	$29K	Buy	+125,000	New	+$32.5K	﹤0.01%	669

Tenor Capital Management's BIOSW Position: Q4 2023 in Review

Tenor Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 125,000 shares — an estimated $7K sold.

Tenor Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $29K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Tenor Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Tenor Capital Management sold 125,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $7K.
Tenor Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Tenor Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $29K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Tenor Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.